ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,837.30
0.08%
Gold vs US Dollar
2,419.59
-0.28%
Brent Oil
82.84
-0.83%
Bitcoin
69,544.83
-2.67%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Precipio Inc (PRPO)

  7. Precipio Inc (PRPO) News

Precipio (PRPO)

Precipio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRPO
DateTimeSourceHeadlineSymbolCompany
14/05/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
06/05/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
06/05/202422:00GlobeNewswire Inc.Precipio Secures a short-term $500K Credit FacilityNASDAQ:PRPOPrecipio Inc
25/03/202421:00GlobeNewswire Inc.Precipio Announces Year end 2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
13/02/202415:00GlobeNewswire Inc.Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYNASDAQ:PRPOPrecipio Inc
06/02/202415:00GlobeNewswire Inc.Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for CancerNASDAQ:PRPOPrecipio Inc
23/01/202415:00GlobeNewswire Inc.Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterNASDAQ:PRPOPrecipio Inc
19/01/202421:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRPOPrecipio Inc
17/01/202415:30GlobeNewswire Inc.Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in JapanNASDAQ:PRPOPrecipio Inc
04/01/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
04/01/202421:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
02/01/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
02/01/202414:00GlobeNewswire Inc.Precipio Announces Christina Valauri joins the Board of DirectorsNASDAQ:PRPOPrecipio Inc
14/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
14/12/202321:30GlobeNewswire Inc.Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024NASDAQ:PRPOPrecipio Inc
16/11/202322:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
16/11/202322:00GlobeNewswire Inc.Precipio Announces Q3-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
13/11/202321:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
31/10/202320:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
26/10/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
18/10/202314:00GlobeNewswire Inc.Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022NASDAQ:PRPOPrecipio Inc
06/10/202321:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
03/10/202315:00GlobeNewswire Inc.Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023NASDAQ:PRPOPrecipio Inc
28/09/202314:00GlobeNewswire Inc.Precipio Continues to Sign New HemeScreen™ CustomersNASDAQ:PRPOPrecipio Inc
25/09/202316:00GlobeNewswire Inc.Precipio Reduces Product Revenue Result Needed for Cash Flow BreakevenNASDAQ:PRPOPrecipio Inc
21/09/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
14/09/202321:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
14/09/202321:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
 Showing the most relevant articles for your search:NASDAQ:PRPO

Your Recent History

LSE
TERN
Tern
LSE
POS
Plexus
LSE
BP.
Bp
LSE
SCLP
Scancell
LSE
VAL
Valirx
LSE
VAST
Vast Resources
LSE
YU.
Yu
LSE
GKP
Gulf Keystone Petroleum
LSE
PHE
Powerhouse Energy
LSE
TEK
Tekcapital
LSE
MIN
Minoan
LSE
SOLG
Solgold
LSE
AAZ
Anglo Asian Mining
LSE
SYME
Supply@me Capital
LSE
ITV
Itv
LSE
CHLL
Chill Brands
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved